Esco Lifesciences Group is a world-leading manufacturer of laboratory and pharmaceutical equipment, bioprocess tools, and IVF medical devices, delivering sustainable workflow solutions to advance global health.
Established in 1978, the Singapore-based company has remained committed to excellence by combining forward-thinking technology with responsive support and proven reliability. This commitment has made Esco a trusted partner for life science and medical markets in more than 150 countries worldwide.
Supporting this mission, the Healthcare Business Unit (Healthcare BU) delivers standardized, configurable platform solutions while ensuring that critical operational parameters remain uncompromised. These systems enable the manufacture of internationally compliant pharmaceutical and biopharmaceutical products, as well as nutraceuticals and cosmeceuticals, while providing safe and sterile work environments for organizations developing next-generation therapies.
Beyond core platforms, the Healthcare BU also offers specialist services, integrated equipment packages, and tailored process solutions built upon its foundational technologies. Together, these offerings enhance operator protection, reduce cross-contamination risks, and improve processing efficiency - supporting safe and sterile operations across highly regulated manufacturing environments.
CONTACT INFORMATION
Esco Lifesciences
2512 Metropolitan Dr
Trevose, PA 19053
UNITED STATES
Phone: +1 215-441-9661
FEATURED INSIGHTS
-
EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.
-
Strategic use of airlocks in downflow booth design enhances pressure stability and containment. A risk-based approach ensures facility integration meets rigorous safety and compliance standards.
-
Advanced wireless testing ensures glove and barrier integrity in sterile manufacturing. These tools support ISO compliance and Annex 1 standards to strengthen contamination control.
-
Rigorous Factory Acceptance Testing ensures filling line isolators meet performance and safety standards. This validation is vital for aseptic integrity and protecting both product and operator.
-
Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.
-
Closed isolator systems provide Grade A aseptic environments necessary for cGMP cell therapy scaling. By integrating essential equipment and automation, these systems ensure rigorous quality control.
-
Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.
-
Strategic equipment relocation and retrofitting can reduce capital costs by fifty percent and save months in lead time. Learn how to modernize legacy systems while maintaining full GMP compliance.